drugset / Trial / NCT06100952
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
RandomizedParallel-groupDouble-blindTreatment
Summary
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Timeline
- Start
- 2023-11-01
- Primary completion
- 2026-02-13
- Completion
- 2026-03-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riboflavin | Other / unclassified | — | Other |
| Subject | Sodium Iodide | Unknown | — | Other |